InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,626.02
(
0.54%
)
US TECH 100
18,986.40
(
0.30%
)
Dow Jones
41,393.78
(
0.72%
)
Brent Oil
71.83
(
0.00%
)
Bitcoin
60,100.11
(
-0.79%
)

Replies to post #98 on Idenix Pharmaceuticals (IDIX)

Replies to #98 on Idenix Pharmaceuticals (IDIX)
icon url

go seek

12/14/06 4:46 PM

#100 RE: dewophile #98

very surprised by the reaction (or lack thereof) of market to yesterday's news. frankly, I don't think it has sunk in yet

I read something about "herd mentality" and the market... i'll post, if i find it. Could the blnd be leading the blind? tis doubtful... perhaps the grim reaper is leading...

In any case, the market action is interesting to follow...



icon url

DewDiligence

12/14/06 8:45 PM

#104 RE: dewophile #98

>very surprised by the reaction (or lack thereof) of market to yesterday's [VRTX] news. frankly, I don't think it has sunk in yet<

An alternate explanation is that there are only two weeks left in the calendar year and the market doesn’t believe IDIX will make good on its pledge to reveal a “creative strategy” for ameliorating the GI side effects with the 800mg dose of NM283 in the treatment-refractory setting.

The market may now recognize that VX-950 is not heaven sent, but it does not necessarily follow that the market thinks NM283 will have an easier time on its own development path.